Get alerts for new trials in your area by subscribing now
Influenza, or flu, is a contagious respiratory infection caused by influenza viruses that spread through coughs, sneezes, and contaminated surfaces. It comes on fast with fever, aches, cough, and exhaustion, and for most people passes within a week or two, but it sends hundreds of thousands of Americans to the hospital in a typical season and is most dangerous for people over 65, young children, pregnant women, and people with heart, lung, or immune conditions. Flu viruses change constantly, which is why the vaccine is reformulated every year and why protection from one season does not carry over to the next.
Antiviral medicines shorten the illness if started within the first two days, and vaccination remains the main way to prevent severe disease. The first mRNA flu vaccine was approved in 2026, and researchers are working toward a universal vaccine that would not need yearly updates. COVID-19 is studied separately on our COVID-19 clinical trials page.
Interested in learning more about flu treatment? Read our guide: Flu Symptoms, Treatment, and Vaccines Explained
Vaccine trials. Updated seasonal vaccines, mRNA and other new technologies, higher dose and adjuvanted vaccines for people 65 and older, and candidate universal vaccines designed to protect against many strains.
Trials for older adults. Studies that enroll only people 65 and older, because the immune response to vaccines weakens with age and this group accounts for most flu hospitalizations.
Observational and immunity studies. Research on how long protection lasts, how prior infections shape the immune response, and how flu interacts with other infections.
Not exactly. Trials that test how well a vaccine or antiviral actually works against a real flu infection typically run during flu season in the U.S., which usually spans from around October through May, since researchers need participants to be naturally exposed to the virus to see meaningful results.
Other types of influenza trials don't depend on flu season at all. Early safety studies and human challenge studies, for example, don't rely on natural exposure, since human challenge studies deliberately expose volunteers to the virus under closely controlled conditions, they can be scheduled at almost any time of year, even outside the typical flu season.
Eligibility for participating in an influenza clinical trial varies depending on the specific study, but generally, both healthy volunteers and people at higher risk of severe flu may qualify, depending on what's being tested. Vaccine trials often look for healthy participants across different age groups, while antiviral and antibody trials may focus on people who've recently been diagnosed with the flu or are at high risk of complications.
For most trials, eligibility criteria often include factors like age, current health status, vaccination history, and the time of year, since many influenza trials run during flu season. Some studies, like human challenge trials, require extensive health screening since participants are deliberately exposed to the virus under close supervision.
When participating in an influenza clinical trial, participants can expect to go through a thorough screening process to make sure they meet the study's specific inclusion and exclusion criteria. Following this, a detailed informed consent will be provided, explaining the study's purpose, procedures, risks, and benefits.
During the trial, participants may receive a vaccine formulation, an antibody, or a placebo, along with regular monitoring through check-ins, symptom tracking, and lab tests to see how their body responds over the course of the study.
Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything.
Curious whether clinical trials pay participants? Here's how compensation actually works.
Enrolling in an influenza clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: